Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
William 'Bill' L. Armstrong, MAI
AddedMar 31, 2024
UpdatedMay 1, 2026
William 'Bill' L. Armstrong, MAI

William 'Bill' L. Armstrong, MAI

Board Member, Cyclo Therapeutics

William 'Bill' L. Armstrong, MAI's Career

Cyclo Therapeutics
Cyclo Therapeutics

Gainesville, FL, US

Board Member· Board
Tracon Pharmaceuticals
Tracon Pharmaceuticals

San Diego, CA, US

Board Member· Board
Fossil Group
Fossil Group

Richardson, TX, US

Board Member· Board
PureForge
PureForge

Poway, CA, US

Board Member· Board
Hawaii Biotech
Hawaii Biotech

Honolulu, HI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

William 'Bill' L. Armstrong, MAI's Career

Cyclo Therapeutics
Cyclo Therapeutics
Public$16.8M91990Gainesville, FL, US
Board Member· Board

Leadership at Cyclo Therapeutics

Markus SiegerMarkus SiegerBoard Member
C.E. Rick StrattanC.E. Rick StrattanFounder
Rick StrattanRick StrattanBoard Member
N. Scott FineN. Scott FineBoard Member
Francis Patrick OstronicFrancis Patrick OstronicBoard Member

Similar to Cyclo Therapeutics

Applied TherapeuticsApplied TherapeuticsNew York City, NY, USDrug Developmentest. 2016Applied TherapeuticsNew York City, NY, US · est. 2016

Applied Therapeutics, a clinical-stage biotech firm, develops transformative drugs for critical medical needs in the US.

Public · $259.1M22
Unicycive TherapeuticsUnicycive TherapeuticsLos Altos, CA, USDrug Developmentest. 2016Unicycive TherapeuticsLos Altos, CA, US · est. 2016

Unicycive Therapeutics: Innovating kidney disease treatments for unmet medical needs.

Public · $36.6M18
Bio Green Med SolutionBio Green Med SolutionBerkeley Heights, NJ, USTherapeuticsest. 1996Bio Green Med SolutionBerkeley Heights, NJ, US · est. 1996

US-based company specializing in R&D of therapeutics for cancer and serious diseases.

Public · $149.5M17
CyTheraCyTheraSan Diego, CA, USCell Therapiesest. 2000CyTheraSan Diego, CA, US · est. 2000

CyThera, Inc.: Biotech firm developing cell replacement therapies for degenerative diseases.

Seed · $2M50
Tracon Pharmaceuticals
Tracon Pharmaceuticals
Public$113M182004San Diego, CA, US
Board Member· Board

Leadership at Tracon Pharmaceuticals

William R. LaRueWilliam R. LaRueBoard Member
Alfred ScheideggerAlfred ScheideggerBoard Member
Charles TheuerCharles TheuerBoard Member
Martin MattinglyMartin MattinglyBoard Member
Bertrand LiangBertrand LiangBoard Member
Carol C LamCarol C LamBoard Member

Similar to Tracon Pharmaceuticals

Tallac TherapeuticsTallac TherapeuticsBurlingame, CA, USCancer Treatments, Immunotherapyest. 2018Tallac TherapeuticsBurlingame, CA, US · est. 2018

Tallac Therapeutics: A biopharmaceutical firm innovating cancer immunotherapy treatments.

Series A · $88.2M34
Trana DiscoveryTrana DiscoveryCary, NC, USDrug Discoveryest. 2000Trana DiscoveryCary, NC, US · est. 2000

US-based Trana Discovery Inc. offers proprietary drug discovery technology solutions.

Series A · $720k30
Tract TherapeuticsTract TherapeuticsChicago, IL, USMedicalest. 2013Tract TherapeuticsChicago, IL, US · est. 2013

Nova Biomedical: Innovating immune balance restoration for solid organ transplant patients.

Series B · $15M5
Crinetics PharmaceuticalsCrinetics PharmaceuticalsSan Diego, CA, USTherapeuticsest. 2008Crinetics PharmaceuticalsSan Diego, CA, US · est. 2008

San Diego-based Crinetics Pharmaceuticals develops therapeutics for endocrine diseases and cancers.

Public · $796M210
Fossil Group
Fossil Group
Public6.9k1984Richardson, TX, US
Board Member· Board

Leadership at Fossil Group

Marc ReyMarc ReyBoard Member
Kevin MansellKevin MansellBoard Member
James E SkinnerJames E SkinnerBoard Member
Gail TiffordGail TiffordBoard Member
Kosta N. KartsotisKosta N. KartsotisBoard Member
Bill ChiassonBill ChiassonBoard Member

Similar to Fossil Group

Invicta Watch GroupInvicta Watch GroupHollywood, FL, USWatchesest. 1837Invicta Watch GroupHollywood, FL, US · est. 1837

InvictaWatch.com: America's rapidly expanding global watch company.

60
International Vintage WatchInternational Vintage WatchBeverly Hills, CA, USWatchesest. 2015International Vintage WatchBeverly Hills, CA, US · est. 2015

International Vintage Watch: A global online retailer of luxury and international wristwatch brands since 2015.

Series A · $2.5M7
Flex WatchesFlex WatchesSan Diego, CA, USApparel, Watchesest. 2010Flex WatchesSan Diego, CA, US · est. 2010

Flex Watches: A fashion brand creating unique watches and clothing, partnering with charities for impactful causes.

Angel · $450k9
HodinkeeHodinkeeNew York City, NY, USAccessories, Watchesest. 2008HodinkeeNew York City, NY, US · est. 2008

HODINKEE: A leading NYC-based online platform for new and vintage wristwatch editorial and e-commerce.

Seed · $43.6M130
PureForge
PureForge
Seed$3.9M302006Poway, CA, US
Board Member· Board

Leadership at PureForge

Thomas M Roskos JrThomas M Roskos JrBoard Member
Nathan K. MeckelNathan K. MeckelFounder

Similar to PureForge

Orbis BrakesOrbis BrakesSanta Rosa, CA, USBrakesest. 2021Orbis BrakesSanta Rosa, CA, US · est. 2021

Orbis Brakes: Unprecedented provider of advanced braking solutions.

Angel · $134.2k30
Forge TechForge TechKemah, TX, USRepair, Strengtheningest. 2010Forge TechKemah, TX, US · est. 2010

Providing repair and strengthening services for equipment using Forge Bonding, a safer, no-shutdown method.

Seed · $175.8k19
Granite ForgeGranite ForgeHudson, NH, USAerospace Components, Medical Implantsest. 2018Granite ForgeHudson, NH, US · est. 2018

Granite Forge: Specialized contract manufacturer of forged, machined medical implants and aerospace parts.

Seed · $7M6
Hawaii Biotech
Hawaii Biotech
Series A$12.4M181982Honolulu, HI, US
Board Member· Board

Leadership at Hawaii Biotech

Enrique CarrazanaEnrique CarrazanaBoard Member
Tom HumphreysTom HumphreysFounder
Richard L. ShermanRichard L. ShermanCEO
Debra Guerin BeresiniDebra Guerin BeresiniBoard Member
Alan KennettAlan KennettBoard Member
Elliot ParksElliot ParksBoard Member

Similar to Hawaii Biotech

AibiosAibiosIrvine, CA, USBiotech, Pharmaceuticalsest. 2018AibiosIrvine, CA, US · est. 2018

AIBIOS: Biotech innovator developing novel molecules to treat immune-related diseases.

Public · $850M6
HI-BioHI-BioSan Francisco, CA, USBiotechest. 2021HI-BioSan Francisco, CA, US · est. 2021

HI-Bio pioneers precision medicine, targeting cellular drivers to treat immune-mediated diseases.

Series B · $215M48
Moat BiotechnologyMoat BiotechnologyOklahoma City, OK, USVaccinesest. 2022Moat BiotechnologyOklahoma City, OK, US · est. 2022

Oklahoma City software firm & biopharmaceutical company developing innovative vaccines.

Series A · $8M5
Biotech HoldingsBiotech HoldingsGaithersburg, MD, USBiotechnology Servicesest. 2019Biotech HoldingsGaithersburg, MD, US · est. 2019

Gaithersburg software company providing biotechnology services.

Seed · $500k5

William 'Bill' L. Armstrong, MAI's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to William 'Bill' L. Armstrong, MAI

William \"Bill\" Van NostrandWilliam \"Bill\" Van NostrandBoard Member · Casa SystemsBill WilliamsonBill WilliamsonCo-Founder · TabulateJohn HayesJohn HayesBoard Member · Ball CorpEd ArnoldEd ArnoldBoard Member · McKessonTom WilliamsTom WilliamsRetired at HomeJames D. Rogers III (Jim)James D. Rogers III (Jim)Board Member · NewMarket